Effects of nicotine dependence treatment in patients with COPD;Wyniki leczenia uzależnienia od nikotyny chorych na przewlekła̧ obturacyjna̧ chorobȩ płuc

Pneumonologia i Alergologia Polska

Volumn 71, Issue 9-10, 2003, Pages 411-417

  Górecka, Dorota ^a   Bednarek, Michał ^a   Nowiński, Adam ^a   Puścińska, Elzbieta ^a   Goljan Geremek, Anna ^a   Zieliński, Jan ^a  

^a Klinika Chorob Płuc   (Poland)

Author keywords

COPD; Minimal intervention; Nicotine dependence; Smoking cessation

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; NICOTINE; NICOTINE PATCH; UNCLASSIFIED DRUG; DOPAMINE UPTAKE INHIBITOR;

ADULT; AIRWAY LIMITATION; AIRWAY RESISTANCE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSERVATIVE TREATMENT; DISEASE COURSE; DRUG DEPENDENCE TREATMENT; EARLY DIAGNOSIS; EXPIRED AIR; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMAL INTERVENTION; PATIENT COUNSELING; SCREENING; SMOKING; SMOKING CESSATION; SPIROMETRY; TOBACCO DEPENDENCE; AGED; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; INTRADERMAL DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; POLAND; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; ATTITUDE TO HEALTH; BUPROPION; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; DOPAMINE UPTAKE INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NICOTINE; POLAND; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 17344390364     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pauwels R, Buist AS, Calverley PM et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
2. US Surgeon-General: The health consequences of smoking: chronic obstructive pulmonary disease. W: US Department of Health and Human Services, Washington DC, 1984.
3. Fletcher CM, Peto R, Tinker CM. The natural history of chronic bronchitis and emphysema. Oxford University Press, Oxford 1976.
4. Anthonisen NR, Connett JE, Kiley JP i wsp.: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994; 272: 1497-1505.
5. Zalecenia Polskiego Towarzystwa Ftizjopneumonologicznego rozpoznawania i leczenia przewlekłej obturacyjnej choroby płuc (PO-ChP). Pneumonol. Alergol. Pol. 2002, 70, supl. 2, 1-42.
6. Zieliński J. i wsp: Wczesne wykrywanie PO-ChP badaniem spirometrycznym grup wysokiego ryzyka. Pneumonol. Alergol. Pol. 2000, 68, 217-225.
7. Czajkowska-Malinowska M. i wsp.: Wpływ wczesnego środowiskowego wykrywania POChP na ograniczenie nalogu palenia tytoniu. Pneumonol Alergol Pol. 2001; 69: 524-529.
8. Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest. 2003; 123: 1916-23.
9. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648
10. Górecka D., Zieliński J: Zadbaj o siebie, czyli jak rzucić palenie. Instytut Gruźlicy i Chorób Płuc, Warszawa, 1999, stron 16.
11. Zalecenia Polskiego Towarzystwa Ftizjopneumonologicznego rozpoznawania i leczenia POChP. Pneumonol. Alergol. Pol. 1997, 65, supl.2, 1-30.
12. Tashkin DP, Kanner R, Bailey W i wsp. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial. Lancet 2001; 357: 1571-1575.
13. Jorenby D.E. i wsp.: A controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation. N. Engl. J. Med. 1999, 340, 685-691.
14. Hajek P.: GP intervention - what is the most effective action ? Pulse Reference Supplement 1988, 48, 43.
15. Górecka D., Bednarek M, Nowiński A. i wsp.: Czynniki określaja̧ce sukces w porzucaniu palenia u osób uczestnicza̧cych w środowiskowych badaniach spirometrycznych. Pneumonol. Alergol. Pol. 2001; 69: 611-616.
16. Porȩbska I., Golecki M., Kasibowska-Kuźniar K. i wsp.: Intensywny program leczenia uzależnienia od nikotyny oparty na stosowaniu bupropionu SR - doświadczenia własne. Pneumomol. Alergol. Pol. 2003; 71, 148-153.